HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevation of liver-galactosylhydroxylysyl glucosyltransferase activity in human primary hepatocellular carcinoma.

Abstract
The activity of L-GGT (EC 2.4.1.66), an enzyme catalyzing the intracellular biosynthesis of collagen, was determined in human primary hepatic cancer, acute viral hepatitis and cirrhotic liver tissues and compared to the mean level of enzyme activity in normal human liver tissues. The mean levels of L-GGT activity in primary hepatocellular carcinoma (PHC), acute viral hepatitis and cirrhotic tissues were 7.78, 2.69 and 2.16 times the mean level of enzyme activity in normal human liver tissues. The mean level of L-GGT activity in PHC was 3.61 times the mean level of L-GGT activity in cirrhosis and 2.90 times the mean value of liver enzyme activity in acute viral hepatitis. The findings in this study provide a basis for the highly elevated serum values of this intracellular enzyme in patients with primary hepatic cancer and the data indicate that L-GGT activity may be increased in primary liver cancer to compensate for an increased rate of collagen synthesis.
AuthorsD M Bolarin
JournalThe International journal of biochemistry (Int J Biochem) Vol. 15 Issue 10 Pg. 1291-3 ( 1983) ISSN: 0020-711X [Print] England
PMID6313446 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucosyltransferases
  • UDP glucose-collagen glucosyltransferase
Topics
  • Adult
  • Carcinoma, Hepatocellular (enzymology)
  • Female
  • Glucosyltransferases (metabolism)
  • Hepatitis, Viral, Human (enzymology)
  • Humans
  • Liver (enzymology)
  • Liver Cirrhosis (enzymology)
  • Liver Neoplasms (enzymology)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: